Agios Pharmaceuticals’ Oral Mitapivat Increases Hemoglobin Levels and Improves Markers of Erythropoiesis in Patients with Non-Transfusion-Dependent Thalassemia » ASH 2020-Figure 5 (1)


Comments are closed.

Secured By miniOrange